Sanjay Shukla is President at aTYR PHARMA INC (LIFE). They have made 13 open-market trades across 2 companies since 2020, most recently 2026-02-04.
CIK 0001671026
10 open-market purchases totalling $286K since 2020, against 3 sales. Across 10 scored buys the stock is up 80.0% at ninety days, and 78.3 points ahead of the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| LIFE | 136,548 | $5.1M |
| ATYR | 157,298 | $28K |
| Total | $5.1M |
Shares reported on the most recent Form 4, priced at the 2026-02-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 40% | 60% |
| Avg Move | +59.5% | +82.0% | +80.0% |
| Alpha | +59.2% | +79.9% | +78.3% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATYR | SELL | 2026-02-04 | 2026-02-04 | $0.98 | $4K | +14.3% | -4.2% | -2.5% |
| LIFE | BUY | 2024-05-31 | 2024-06-03 | $1.81 | $36K | +587.6% | +805.9% | +805.9% |
| LIFE | BUY | 2023-12-11 | 2023-12-12 | $1.18 | $18K | +12.5% | +30.0% | +33.3% |
| LIFE | BUY | 2023-11-10 | 2023-11-13 | $1.11 | $17K | +0.0% | +0.0% | +62.8% |
| LIFE | BUY | 2023-07-28 | 2023-08-01 | $2.01 | $30K | +0.5% | -14.6% | -37.2% |
| LIFE | BUY | 2022-11-21 | 2022-11-21 | $2.14 | $21K | +7.4% | -4.2% | +0.9% |
| LIFE | BUY | 2022-07-01 | 2022-07-06 | $2.88 | $43K | -1.0% | +19.1% | +0.7% |
| LIFE | BUY | 2022-01-07 | 2022-01-10 | $6.76 | $34K | -13.8% | -16.4% | -29.5% |
| LIFE | BUY | 2021-11-15 | 2021-11-15 | $8.58 | $21K | -6.6% | -6.6% | -40.2% |
| LIFE | BUY | 2021-05-18 | 2021-05-20 | $4.01 | $40K | +5.2% | -2.7% | +5.2% |
| LIFE | SELL | 2021-02-09 | 2021-02-09 | $7.66 | $6K | -29.3% | -34.4% | -49.7% |
| LIFE | BUY | 2020-06-19 | 2020-06-23 | $4.27 | $26K | +3.2% | +9.7% | -2.2% |
| LIFE | SELL | 2020-02-07 | 2020-02-07 | $4.03 | $3K | +7.4% | -17.4% | -7.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.